Kennesaw, GA – According to filings with the U.S. Securities and Exchange Commission, Cryolife is raising $20,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Patrick Mackin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cryolife

CryoLife’s mission is to restore patients’ health and quality of life by delivering innovative technologies. CryoLife is one of the world’s leading contemporary medical device companies, providing preserved human tissues for cardiac and vascular surgeries, mechanical heart valves for aortic or mitral valve replacement, surgical adhesives and sealants, cardiac lasers for treatment of refractory angina, and state-of-the-art technology and surgical training in adult and pediatric cardiovascular surgery.

To learn more about Cryolife, visit http://www.cryolife.com/

Contact:
Patrick Mackin, President and Chief Executive Officer
770-419-3355
patrick.mackin@cryolife.com
https://www.linkedin.com/in/pat-mackin-b52a303/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved